Supreme Court Ruling Frees India State To Try Two Ranbaxy Drug Cases
This article was originally published in PharmAsia News
Executive Summary
In the wake of India's Supreme Court ruling that cleared Kerala's High Court to take on a criminal case involving drugs made by Ranbaxy Laboratories, the state court now has two company cases on its docket.
In the wake of India's Supreme Court ruling that cleared Kerala's High Court to take on a criminal case involving drugs made by Ranbaxy Laboratories, the state court now has two company cases on its docket. The Supreme Court denied Ranbaxy's appeals to quash both cases, one of the denials a reversal of its decision earlier to issue a stay. The latter case involved Kerala state charges that Ranbaxy's amoxicillin tablets shorted the stated active pharmaceutical ingredient and the other charged the firm with selling its Rosatin Gel Tab as a dietary supplement rather than a regulated drug. (Click here for more
)
"Two Criminal Cases Await Ranbaxy Pharmaceuticals In Kerala" - Economic Times (India) (5/5/2014)